Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

MET earnings analysis

Filed May 7, 2026 · Our reading of the company's report

The latest report

In Q1 2026, MetLife reported strong financial performance, surpassing EPS and revenue expectations. Revenue reached $19.07 billion, up from $18.57 billion in Q1 2025, translating to an impressive growth rate of…

Read full summary

In Q1 2026, MetLife reported strong financial performance, surpassing EPS and revenue expectations. Revenue reached $19.07 billion, up from $18.57 billion in Q1 2025, translating to an impressive growth rate of approximately 2.8%. EPS also climbed significantly to $2.42 compared to $1.28 in the previous year, reflecting robust operational strength within its segments. Adjusted earnings and net income showed notable year-over-year improvements, indicating effective cost management and strategic growth initiatives.

Read the original on SEC.gov

Reported figures

Earnings per share
$2.42
Segment
Group Benefits
Segment
RIS
Segment
Asia
Segment
Latin America
Segment
EMEA
Segment
MIM
Segment
Corporate & Other

What stood out

  • Revenue Growth of 2.8% YoY

    Q1 2026 revenue increased to $19.07 billion from $18.57 billion in Q1 2025.

  • Significant EPS Growth

    EPS increased to $2.42 in Q1 2026, up from $1.28 in Q1 2025.

  • Improved Net Income

    Net income attributable to common shareholders increased to $1.14 billion, up from $879 million YoY.

  • Strong Segment Contribution

    Group Benefits and other segments saw adjusted revenue growth, with Group Benefits increasing to $6.54 billion.

  • Surpassed Revenue Estimates

    Actual revenue exceeded the estimate by approximately 1.5%.

  • Excellent Performance in Investment Management

    MetLife's investment management segment reported a notable increase in institutional client AUM, reflecting growth from the PineBridge acquisition.

What to watch

  • Increased Debt Levels

    Long-term debt increased to $14.45 billion from $14.47 billion, which may elevate interest expenses.

  • Market Volatility Impact

    The company's exposure to market fluctuations resulted in unfavorable net investment losses of $670 million in the current quarter.

  • Regulatory Challenges

    Ongoing regulatory changes may impose additional compliance costs and operational barriers.

Management's outlook

No explicit forward guidance provided in MD&A.

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.